- ￥5600
- GeneTex
- 美国
- GTX85020
- 2025年07月15日
- WB, ICC/IF, ELISA
- Rabbit
- Human, Mouse, Rat
企业认证
相关产品推荐更多 >
![PTEN antibody [1B8]](https://img1.dxycdn.com/2022/0328/526/9220117805367500453-14.jpg!wh200)
![CD99 antibody [PCB1]](https://img1.dxycdn.com/2022/0328/069/6349932695628700453-14.jpg!wh200)
![IL6 antibody [GT519-1]](https://img1.dxycdn.com/2022/0329/667/7952656984609020453-14.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
RNAse H2A antibody was raised against a 17 amino acid synthetic peptide near the center of human RNAse H2A.The immunogen is located within amino acids 190 - 240 of RNAse H2A.
- 亚型：
IgG
- 形态：
Liquid
- 保存条件：
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
- 克隆性：
Polyclonal
- 标记物：
Unconjugated
- 适应物种：
Human, Mouse, Rat
- 保质期：
12 months from the shipping date of the product.
- 抗原来源：
Human
- 目录编号：
GTX85020
- 级别：
Primary Antibodies
- 库存：
Available
- 供应商：
GeneTex
- 宿主：
Rabbit
- 应用范围：
WB, ICC/IF, ELISA
- 浓度：
1 mg/ml (Please refer to the vial label for the specific concentration.)
- 靶点：
RNAse H2A
- 抗体英文名：
RNAse H2A antibody
- 抗体名：
RNAse H2A 抗体
- 规格：
100 μg
ICC/IF analysis of HeLa cells using GTX85020 RNAse H2A antibody.
Working concentration : 2 μg/ml
WB analysis of HeLa cell lysate using GTX85020 RNAse H2A antibody.
Working concentration : 1 μg/ml
ICC/IF analysis of HeLa cells using GTX85020 RNAse H2A antibody.
Working concentration : 5 μg/ml
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Ghodgaonkar MM et al., Mol Cell 2013 (PMID:23603115)
Preparation of Recombinant RNase Single-Chain Antibody Fusion Proteins
Selective cytotoxicity is an important goal of specific drug targeting. Toward this end, toxins isolated primarily from higher plants and bacteria have been coupled to monoclonal antibodies (MAbs) and evaluated for their clinical efficacy
Construction and Characterization of RNase-Based Targeted Therapeutics
Cell targeting agents such as antibodies, antibody fragments (sFvs), or growth factors have been conjugated or genetically fused to a variety of plant and bacterial toxins. These targeted therapeutics, termed “immunotoxins
Inducing RNAi with siRNA Cocktails Generated by RNase III
by an RNase III-like endoribonuclease (Dicer) producing siRNAs that are 21-23 bp in length and contain 3' dinucleotide overhangs with 5'-phosphate and 3'-hydroxyl termini. These siRNAs mediate degradation of homologous transcripts, leading to gene silencing
技术资料暂无技术资料 索取技术资料
